Labour market · 30/09/2003Updated: 10/17/2026 · 1 min read

Heraeus Electro-Nite Company Receives Negative Determination on Reconsideration Application

Summary

The company, based in Philadelphia, PA, has been informed of a negative determination by the relevant authorities regarding its application for reconsideration, following a previous negative determination

Original source language: Federal Register — Department of LaborOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Labour market · 10/22/2026

Georgiamune and the Menarini Group conclude an exclusive global licensing and collaboration agreement on GIM-621, an innovative oral immuno-oncological agent

GIM-621 is an innovative, preclinical, small molecule oral immunotherapy that has potential for application in the treatment of several solid tumours.

Read summary →

Labour market · 10/22/2026

Labcorp, Charles River and FDA announce research collaboration to advance preclinical methods for evaluating potential drug abuse

Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisions BURLINGTON, N.C., Oct. 22, 2026 /PRN...

Read summary →

Labour market · 10/22/2026

Tairex launched a multi-agent AI system to transform the collaboration clinique and help in decision making.

PÉKIN, 22 October 2026 — On 21 October, Tairex, a health technology society based on AI incubated by the Institute for AI Industry Research (AIR) of Tsinghua University, unveiled an ecosystem...

Read summary →

Labour market · 10/22/2026

Georgiamune and Menarini Group enter into an exclusive global license and collaboration agreement for GIM-621, a first-in-class oral immuno-oncology agent

GIM-621 is a preclinical stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors.

Read summary →

Labour market · 10/22/2026

Real Diagnostics acquires SimplyTest, expands its high-complexity laboratory portfolio with saliva-based oral health testing

The acquisition adds periodontal health testing to Real Diagnostics' molecular diagnostic laboratory offering for dental providers.

Read summary →